Appendix S1 - Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
收藏数据链接：
官方服务：
资源简介：
Independent ethics committees/institutional review boards for participating study centers in the DELIVER study. (DOCX)
创建时间：
2015-12-02
